Regulatory Alerts
Stay ahead of FDA approvals, 483 inspections, exclusivity expiries, and drug shortages
Recent regulatory signals across approvals, inspection events, exclusivity timelines, and active drug shortages — filterable by company and time window.
Approvals
New ANDA, NDA & BLA approvals, first-generics flagged.
Form 483s
Inspection events with site & volume context.
Exclusivity
Expiries — expired & expiring soon.
Drug Shortages
Active shortages with affected NDCs & exposure.
Sign in to view FDA Alerts
Real-time approvals, Form 483 inspections, exclusivity expiries and drug shortages — available to logged-in users.